Literature DB >> 1203865

Hodgkin's disease in the bone marrow.

R B Weiss, R D Brunning, B J Kennedy.   

Abstract

Tumor involvement of the bone marrow in patients with Hodgkin's disease may be suspected in the presence of other manifestations of advanced disease such as fever, lymphopenia, hypoalbuminemia, mixed cellular histologic type, or Stage III or IV disease by other clinical parameters. It occurs more frequently in the older age groups. When anemia, leucopenia, and/or thrombocytopenia are present and are unrelated to recent bone marrow suppressant chemotherapy, marrow involvement is likely to be present. Bone marrow examination, done by multiple trephine biopsies, provides an adequate sampling of tissue and results in a high incidence of detection of involvement by Hodgkin's disease. This manifestation of Hodgkin's disease is associated with a relatively short survival. Aggressive combination chemotherapy is necessary to produce a significant remission.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1203865     DOI: 10.1002/cncr.2820360924

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Features and prognosis of chemotherapy-treated Hodgkin's disease with initial bone marrow involvement.

Authors:  G Auclerc; M F Auclerc; M Weil; J M Andrieu; C Jacquillat; J Bernard
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  [The significance of histologic assessment of the bone marrow in Hodgkin's disease].

Authors:  R Bartl; R Burkhardt; H Lengsfeld; D Huhn
Journal:  Klin Wochenschr       Date:  1976-11-15

3.  Prognostic factors in COPP-treated patients with Hodgkin's disease.

Authors:  W Gassmann; L Perenyi; N Schmitz; W Kayser; H Pralle; H Löffler
Journal:  Blut       Date:  1982-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.